Myelofibrose: Dritter JAK-Inhibitor in Leitlinie aufgenommen

Im Focus Onkologie 2026

View at publisher
Authors: Redaktion Facharztmagazine
DOI: 10.1007/s15015-025-4488-3
Cited by: 0

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Acute Myeloid Leukemia Research

Publication details

Journal / source
Im Focus Onkologie
Volume
29
Issue
1-2
Pages
54–54
Publication date
1 February 2026
Language
DE